116 related articles for article (PubMed ID: 19624873)
1. [Correlation of plasma thioredoxin reductase activity to growth of H22 hepatocellular carcinoma xenografts in Kunming mice].
Tan Q; Ren XY; Li J; Wang F; Deng SJ; Zeng HH
Ai Zheng; 2009 May; 28(5):472-7. PubMed ID: 19624873
[TBL] [Abstract][Full Text] [Related]
2. Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model.
Ye SF; Li J; Ji SM; Zeng HH; Lu W
Acta Pharmacol Sin; 2017 Feb; 38(2):223-232. PubMed ID: 27917873
[TBL] [Abstract][Full Text] [Related]
3. Serum thioredoxin reductase is highly increased in mice with hepatocellular carcinoma and its activity is restrained by several mechanisms.
Zhang L; Cheng Q; Zhang L; Wang Y; Merrill GF; Ilani T; Fass D; Arnér ESJ; Zhang J
Free Radic Biol Med; 2016 Oct; 99():426-435. PubMed ID: 27581528
[TBL] [Abstract][Full Text] [Related]
4. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
[TBL] [Abstract][Full Text] [Related]
5. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen.
Zheng X; Chen Y; Bai M; Liu Y; Xu B; Sun R; Zeng H
Free Radic Biol Med; 2019 Feb; 131():7-17. PubMed ID: 30496814
[TBL] [Abstract][Full Text] [Related]
6. A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines.
Zhao F; Yan J; Deng S; Lan L; He F; Kuang B; Zeng H
Cancer Lett; 2006 May; 236(1):46-53. PubMed ID: 15982805
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
8. Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis.
Ye SF; Yang Y; Wu L; Ma WW; Zeng HH
J Zhejiang Univ Sci B; 2017 May; 18(5):373-382. PubMed ID: 28471109
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanism of ethaselen in poorly differentiated colorectal RKO cell growth inhibition: Simultaneous regulation of TrxR transcription, expression and enzyme activity.
Yin H; Li J; Xiong K; Wang L; Wang T; Tan Q; Fu J; Ren X; Zeng H
Differentiation; 2011 Jan; 81(1):49-56. PubMed ID: 20864247
[TBL] [Abstract][Full Text] [Related]
10. Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.
Zheng X; Ma W; Sun R; Yin H; Lin F; Liu Y; Xu W; Zeng H
Redox Biol; 2018 Apr; 14():237-249. PubMed ID: 28965082
[TBL] [Abstract][Full Text] [Related]
11. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
[TBL] [Abstract][Full Text] [Related]
12. Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo.
Tan Q; Li J; Yin HW; Wang LH; Tang WC; Zhao F; Liu XM; Zeng HH
Invest New Drugs; 2010 Jun; 28(3):205-15. PubMed ID: 19271154
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo.
Xing F; Li S; Ge X; Wang C; Zeng H; Li D; Dong L
Oral Oncol; 2008 Oct; 44(10):963-9. PubMed ID: 18282784
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glutathione synthesis eliminates the adaptive response of ascitic hepatoma 22 cells to nedaplatin that targets thioredoxin reductase.
Wang Y; Lu H; Wang D; Li S; Sun K; Wan X; Taylor EW; Zhang J
Toxicol Appl Pharmacol; 2012 Dec; 265(3):342-50. PubMed ID: 22982619
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
Wang X; Zhang J; Xu T
Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
[TBL] [Abstract][Full Text] [Related]
16. [Sodium nitrite improves epithelial-mesenchymal transition of hepatoma cells in mice bearing H22].
Xu HR; Lin B; Wang SQ; Zhang Z; Lu XX; Liu Y; Chao-Shen HF
Yao Xue Xue Bao; 2012 Nov; 47(11):1470-6. PubMed ID: 23387079
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest.
Fu JN; Li J; Tan Q; Yin HW; Xiong K; Wang TY; Ren XY; Zeng HH
Invest New Drugs; 2011 Aug; 29(4):627-36. PubMed ID: 20195699
[TBL] [Abstract][Full Text] [Related]
18. A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells.
Peng ZF; Lan LX; Zhao F; Li J; Tan Q; Yin HW; Zeng HH
J Zhejiang Univ Sci B; 2008 Jan; 9(1):16-21. PubMed ID: 18196608
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells.
Gan L; Yang XL; Liu Q; Xu HB
J Cell Biochem; 2005 Oct; 96(3):653-64. PubMed ID: 16088946
[TBL] [Abstract][Full Text] [Related]
20. Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy.
Wang L; Fu JN; Wang JY; Jin CJ; Ren XY; Tan Q; Li J; Yin HW; Xiong K; Wang TY; Liu XM; Zeng HH
Anticancer Drugs; 2011 Sep; 22(8):732-40. PubMed ID: 21562407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
